Announcements Trials
Browse Landscape

Phase

Phase 2 9Phase 3 6Phase 1/2 3Phase NA 2Phase 2/3 2Phase 1 1

Status

Unknown 1Recruiting 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Gastrointestinal 2

Conditions

Rectal Neoplasms 3Breast Neoplasms 3Esophageal Squamous Cell Carcinoma 2Colonic Neoplasms 2Carcinoma, Hepatocellular 2Recurrence 1Pancreatic Neoplasms 1Ovarian Neoplasms 1Oesophagogastric Cancer 1Neoplasms 1Inflammatory Breast Neoplasms 1Fallopian Tube Neoplasms 1Colorectal Neoplasms 1Cholangiocarcinoma 1Carcinoma, Ovarian Epithelial 1Carcinoma, Non-Small-Cell Lung 1

Interventions

Cisplatin 8Radiotherapy 6Fluorouracil 4Paclitaxel 3tislelizumab 2nimotuzumab 2Neoadjuvant Therapy 2Esophagectomy 2Drug Therapy 2Capecitabine 2spartalizumab 1pembrolizumab 1anlotinib 1TP protocol 1Surgical Procedures, Operative 1Radiation 1Oxaliplatin 1Nivolumab 1Leucovorin 1Immunotherapy 1Docetaxel 1Clinical Trials, Phase II as Topic 1Chemoradiotherapy 1Cetuximab 1130-nm albumin-bound paclitaxel 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 2/3 × Esophageal Squamous Cell Carcinoma × Neoadjuvant Therapy × Clear all
NCT04973306 2022-06-30

iCROSS

Shanghai Zhongshan Hospital

Phase 2/3 Recruiting
176 enrolled
Gastrointestinal

Esophageal Squamous Cell Carcinoma

NCT03623737 2022-06-07

Comparing Paclitaxel/Cisplatin and Cisplatin/5-fluorouracil in Neo-CRT for ESCC

National Taiwan University Hospital

Phase 2/3 Unknown
248 enrolled
Gastrointestinal

Esophageal Squamous Cell Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡